BDX
Becton, Dickinson and CompanyHealthcare · $49.6B market cap
Verdict
Share price
$176.80
close of Oct 3, 2026
Fair value
$147.72
Sticker Price
Payback Price
$59.09
buy price
BDX is Overpriced: at $176.80 it trades 20% above its fair value of $147.72. Its buy price (Payback Price) is $59.09, 67% below today's price. Business quality is limited: only 1 of 5 key numbers clears the 10% bar.
How we valued it
Free Cash Flow Growth. Free cash flow is growing faster than reported earnings, so we project free cash flow 10 years ahead instead.
Business quality
1 of 5 clear the 10% bar. What are the Big Five?
Follow BDX
Get notified when it reaches its buy price of $59.09. Free.
Create a free accountInsider activity
Since Jun 24, 2026: no open-market purchases, 6 sales worth $1.4M and 8 other filings (stock awards, tax withholding and similar). Why purchases matter
Sales
Feld Michael
EVP, Chief Revenue Officer · 2026-08-26
Sold
$31K
Polen Thomas E Jr
Chairman, CEO and President · 2026-08-13
Sold
$768K
Goette Roland
EVP and President, EMEA · 2026-08-11
Sold
$441K
Feld Michael
EVP, Chief Revenue Officer · 2026-07-27
Sold
$12K
Feld Michael
EVP, Chief Revenue Officer · 2026-06-26
Sold
$11K
Show all 6 salesShow fewer
Garrison Michael David
EVP & Pres Med.Essntl&BioPharm · 2026-06-24
Sold
$160K
Other filings
Roque Vitor
EVP & Chief Financial Officer · 2026-09-02
Tax withholding
190 shares
Feld Michael
EVP, Chief Revenue Officer · 2026-08-20
Tax withholding
1,049 shares
Polen Thomas E Jr
Chairman, CEO and President · 2026-08-13
D-Return
$7.2M
Polen Thomas E Jr
Chairman, CEO and President · 2026-08-13
Option exercise
$7.2M
Byington Carrie L
director · 2026-08-06
Award
94 shares
About Becton, Dickinson and Company
Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers…
Medical - Instruments & Supplies
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works